Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NasuMel Gel for chronically infected radical mastoid cavities
2011-001407-13Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Apr 2011
- Countries
- 1
01
Overview
Phase 2, randomised trial of NasuMel in Mastoidectomy cavity infection and Mastoiditis (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Number of hospital contacts for infection/discharge over 12 weeks. Started Apr 2011; status: completed.
02
Drugs
NasuMel
03
Conditions
Mastoidectomy cavity infectionMastoiditis
Beyond the preview
Go deeper on 2011-001407-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001407-13.